Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Innate Immune Training with Bacterial Extracts Enhances Lung Macrophage Recruitment to Protect from Betacoronavirus Infection.

Tytuł:
Innate Immune Training with Bacterial Extracts Enhances Lung Macrophage Recruitment to Protect from Betacoronavirus Infection.
Autorzy:
Salzmann M; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria.
Haider P; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.
Kaun C; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.
Brekalo M; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.
Hartmann B; Institute of Veterinary Disease Control, AGES, Mödling, Vienna, Austria.
Lengheimer T; Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Pichler R; Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Filip T; Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Derdak S; Medical University of Vienna, Core Facilities, Vienna, Austria.
Podesser B; Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria.; Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Hengstenberg C; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.
Speidl WS; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.
Wojta J; Department of Internal Medicine II/Cardiology, Medical University of Vienna, Vienna, Austria.; Medical University of Vienna, Core Facilities, Vienna, Austria.
Plasenzotti R; Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Hohensinner PJ; Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria.; Center for Biomedical Research, Medical University of Vienna, Vienna, Austria.
Źródło:
Journal of innate immunity [J Innate Immun] 2022; Vol. 14 (4), pp. 293-305. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : Karger, c2009-
MeSH Terms:
Adjuvants, Immunologic*
Betacoronavirus*
Animals ; Bacteria ; Immunity, Innate ; Lung ; Macrophages ; Mice
References:
Trends Immunol. 2020 Dec;41(12):1083-1099. (PMID: 33153908)
PLoS One. 2017 Nov 28;12(11):e0188010. (PMID: 29182620)
J Exp Med. 1949 Sep;90(3):181-210. (PMID: 18137294)
Circ Res. 2020 Jul 31;127(4):571-587. (PMID: 32586214)
Nat Immunol. 2021 Jan;22(1):2-6. (PMID: 33293712)
Sci Rep. 2017 Mar 06;7:43844. (PMID: 28262817)
PLoS Biol. 2018 Jul 3;16(7):e2005970. (PMID: 29969450)
J Virol. 2015 Feb;89(3):1523-36. (PMID: 25428866)
J Infect Dis. 2021 Aug 2;224(3):395-406. (PMID: 33493287)
J Exp Med. 2020 Jun 1;217(6):. (PMID: 32353870)
Expert Rev Respir Med. 2020 Oct;14(10):1019-1026. (PMID: 32635771)
Arch Virol. 1989;104(3-4):187-96. (PMID: 2468325)
Microorganisms. 2020 Nov 17;8(11):. (PMID: 33213053)
Genome Biol. 2014;15(12):550. (PMID: 25516281)
Bioinformatics. 2011 Jun 15;27(12):1739-40. (PMID: 21546393)
Proc Natl Acad Sci U S A. 2021 May 25;118(21):. (PMID: 34006644)
J Virol. 2007 Jan;81(2):568-74. (PMID: 17079305)
Eur Respir J. 2020 Apr 16;55(4):. (PMID: 32269085)
J Immunol. 2009 Jan 15;182(2):1099-106. (PMID: 19124753)
Cell Syst. 2015 Dec 23;1(6):417-425. (PMID: 26771021)
BMC Bioinformatics. 2011 Aug 04;12:323. (PMID: 21816040)
Nat Genet. 2003 Jul;34(3):267-73. (PMID: 12808457)
Viruses. 2020 Aug 12;12(8):. (PMID: 32806708)
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. (PMID: 16199517)
Front Med (Lausanne). 2014 Oct 30;1:41. (PMID: 25593914)
J Exp Med. 2008 Dec 22;205(13):3065-77. (PMID: 19064696)
Pulm Pharmacol Ther. 2014 Feb;27(1):109-13. (PMID: 23792312)
Front Immunol. 2018 Sep 11;9:2061. (PMID: 30254639)
Lab Anim Sci. 1998 Feb;48(1):50-4. (PMID: 9517890)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Nat Rev Immunol. 2005 May;5(5):375-86. (PMID: 15864272)
Arch Virol. 1989;107(3-4):171-7. (PMID: 2554852)
Cell Tissue Res. 2011 Jan;343(1):97-106. (PMID: 20824285)
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8094-8103. (PMID: 32198201)
Nature. 2020 Aug;584(7821):463-469. (PMID: 32717743)
PLoS Pathog. 2015 Sep 14;11(9):e1005155. (PMID: 26367131)
Nature. 2015 Feb 26;518(7540):547-51. (PMID: 25470051)
Contributed Indexing:
Keywords: Bacterial extract; Macrophage; Mouse coronavirus; Trained immunity
Substance Nomenclature:
0 (Adjuvants, Immunologic)
Entry Date(s):
Date Created: 20211114 Date Completed: 20220707 Latest Revision: 20220917
Update Code:
20240104
PubMed Central ID:
PMC9059017
DOI:
10.1159/000519699
PMID:
34775384
Czasopismo naukowe
Training of the innate immune system with orally ingested bacterial extracts was demonstrated to have beneficial effects on infection clearance and disease outcome. The aim of our study was to identify cellular and molecular processes responsible for these immunological benefits. We used a murine coronavirus (MCoV) A59 mouse model treated with the immune activating bacterial extract Broncho-Vaxom (BV) OM-85. Tissue samples were analysed with qPCR, RNA sequencing, histology, and flow cytometry. After BV OM-85 treatment, interstitial macrophages accumulated in lung tissue leading to a faster response of type I interferon (IFN) signalling after MCoV infection resulting in overall lung tissue protection. Moreover, RNA sequencing showed that lung tissue from mice receiving BV OM-85 resembled an intermediate stage between healthy and viral infected lung tissue at day 4, indicating a faster return to normal tissue homoeostasis. The pharmacologic effect was mimicked by adoptively transferring naive lung macrophages into lungs from recipient mice before virus infection. The beneficial effect of BV OM-85 was abolished when inhibiting initial type I IFN signalling. Overall, our data suggest that BV OM-85 enhances lung macrophages allowing for a faster IFN response towards a viral challenge as part of the oral-induced innate immune system training.
(© 2021 The Author(s) Published by S. Karger AG, Basel.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies